July 2017

Dr Viktor H. Koelzer, Wellcome Trust Centre for Human Genetics
Prof Tim Maughan, CRUK/MRC Oxford Institute for Radiation Oncology
Expression and polymorphisms of the pattern recognition receptors Stimulator of Interferon Genes (STING) and Toll-like Receptor (TLR) 4 as predictors of disease free survival in the Short Course Oncology Treatment (SCOT) trial of stage II-III colorectal cancer patients.

Mr Puneet Plaha, Oxford University Hospitals NHS Foundation Trust
Mr James Livermore, Department of Neurosurgery
Using night vision goggles to increase the precision of brain tumour surgery

Dr Bart Cornelissen, Department of Oncology
Peptide radionuclide imaging and therapy for pancreatic neuroendocrine tumours

Dr Heidi Olzscha, Department of Oncology
Characterisation of the citrullinome in malignant cell model systems

Dr Alvina G Lai, Professor Jane A McKeating, Target Discovery Institute, Nuffield Department of Medicine
Hypoxic-gene signatures in hepatitis B virus infection that predict hepatocellular carcinoma progression

Dr Vincenzo D’Angiolella, Department of Oncology
A system wide approach to investigate the role of deoxyribonucleotides (dNTPs) in genome stability and cancer cell survival

Dr Richard Owen, Ludwig Cancer Research
An integrative analysis of genomic, proteomic and histology image features in oesophageal metaplasia, dysplasia, and adenocarcinoma.

Dr Enric Domingo, Department of Oncology
Assessment of formalin-fixed paraffin embedded DNA for genome-wide associations studies

Dr Joshua W Owen, IBME
The development of oxygen loaded nanodroplets designed to deliver oxygen under the application of ultrasound for the treatment of tumour hypoxia.

Dr Ole Tietz, Department of Oncology
Intracellular targeting of cancer testis antigens (CTAs) using multimeric cell penetrating peptide (CPPs) clusters